Specialty Generics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Specialty Generics Market
The Specialty Generics market size was valued at USD 76.65 billion in 2023, and the market is now projected to grow from USD 86.86 billion in 2024 to USD 274.76 billion by 2032, exhibiting a CAGR of 15.5% during the forecast period of 2024-2032.
The impact of COVID-19 widespread driven to a slower development of the market as numerous clinical trials and studies were stopped after the major flare-up of the infection and lockdown limitations within the fabricating plants and deficiency of gifted labor. Additionally, a few pharmaceutical companies experienced a decrease in their net deals in 2020 due to the effect of COVID-19.
Numerous pharmaceutical, biopharmaceutical, and medical device companies have expanded their center on growing their market nearness by emphasizing on mergers and acquisitions. Such developing mergers and acquisitions will reinforce the healthcare frameworks whereas upgrading choice and access to basic medications universally.
Expanding cases of different life-threatening infections, counting cancers, Numerous Sclerosis (MS), and HIV, has been expanding globally, which is expected to extend the adoption of specialty medications universally. In addition, constant malady could be a issue fundamentally inclined in developing nations. Persistent infections were the essential reason for mortality in five of the WHO's six districts. Infectious illnesses, such as HIV and other conditions, are still overwhelming in Sub-Saharan Africa and are expected to win in the close future. The market is anticipated to develop quickly due to the high predominance of life-threatening illnesses amid the forecast period.
Comprehensive Analysis Of Specialty Generics Market
Based on course of organization, the advertise is partitioned into injectable, verbal, and others. The verbal portion created the most noteworthy income in 2023. Verbal generics are the foremost helpful, least difficult, and most secure course of administration. They are the foremost utilized and fabricated shape of drugs owing to their comfort for rehashed and drawn out utilize and can be self-administered and are pain-free. Based on indication, the advertise is classified as oncology, cardiovascular, autoimmune diseases, infectious diseases, and others. The oncology portion accounted for the most elevated advertise income share in 2023. The segmental development is due to expanding number of generic drugs for treating cancer and developing demand for compelling cancer treatment treatments. Based on conveyance channel, the market is portioned into clinic drug stores, retail drug stores, and online drug stores. The clinic drug stores portion ruled the advertise with the most elevated income in 2023. The dominance was primarily ascribed to expanding medicine of drugs at clinics due to more visits analyze at these institutions.
North America accounted for critical forte generics market share with a revenue of USD 36.33 billion in 2023. Pharmaceutical organizations are constantly making endeavors to commercialize specialty drugs within the region. This has been driving the development of the advertise in North America.
Endo Pharmaceuticals Inc. (U.S.), Novartis AG (U.S.), Amneal Pharmaceuticals LLC (U.S.), Teva Pharmaceuticals USA, Inc. (U.S.), Viatris Inc. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Mallinckrodt (U.K.), Sun Pharmaceutical Industries, Ltd. (India), Lupin (India), Dr. Reddy's Laboratories, Ltd. (India) are the noticeable key players, capturing an impressive worldwide market share in 2023. The driving position of these companies is basically credited to solid item offerings, counting strength generics.
In April 2023 thecompany Endo Worldwide plc reported the dispatch of a nonexclusive adaptation of Noxafil (posaconazole) verbal suspension for the treatment of oropharyngeal candidiasis.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2023
Estimated Year 2024
Forecast Period 2024-2032
Historical Period 2019-2022
Growth Rate CAGR of 15.5% from 2024-2032
Unit Value (USD Billion)
Segmentation By Route of Administration
Injectable
Oral
Others
By Indication
Oncology
Cardiovascular
Autoimmune Diseases
Infectious Diseases
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America (By Route of Administration, By Indication, By Distribution Channel, and By Country)
- U.S.
- Canada
Europe (By Route of Administration, By Indication, By Distribution Channel, and By Country/Sub-Region)
- Germany
- U.K.
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
Asia Pacific (By Route of Administration, By Indication, By Distribution Channel, and By Country/Sub-Region)
- India
- China
- Japan
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Rest of the World ( By Route of Administration, By Indication, and By Distribution Channel)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Key Industry Developments –Mergers, Acquisitions and Partnerships
- 4.2. Porters Five Forces Analysis
- 4.3. PEST Analysis
- 4.4. Technological Development
- 4.5. Impact of Covid-19
- 5. Global Electric Van Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Key Findings / Definitions
- 5.2. Market Analysis, Insights and Forecast – By Propulsion Type
- 5.2.1. Battery Electric Vehicle (BEV)
- 5.2.2. Hybrid Vehicle (HEV)
- 5.3. Market Analysis, Insights and Forecast – By Range
- 5.3.1. Up to 100 Miles
- 5.3.2. 100-200 Miles
- 5.3.3. Above 200 Miles
- 5.4. Market Analysis, Insights and Forecast – By Battery Capacity
- 5.4.1. Up to 50 kWh
- 5.4.2. Above 50 kWh
- 5.5. Market Analysis, Insights and Forecast – By Component
- 5.5.1. Traction Battery Pack
- 5.5.2. Powertrain
- 5.5.3. Others (Thermal System, Body & Chassis, Braking, Wheels & Suspension System etc.)
- 5.6. Market Analysis, Insights and Forecast – By Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia pacific
- 5.6.4. Rest of the world
- 6. North America Electric Van Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast – By Propulsion Type
- 6.1.1. Battery Electric Vehicle (BEV)
- 6.1.2. Hybrid Vehicle (HEV)
- 6.2. Market Analysis, Insights and Forecast – By Range
- 6.2.1. Up to 100 Miles
- 6.2.2. 100-200 Miles
- 6.2.3. Above 200 Miles
- 6.3. Market Analysis, Insights and Forecast – By Battery Capacity
- 6.3.1. Up to 50 kWh
- 6.3.2. Above 50 kWh
- 6.4. Market Analysis, Insights and Forecast – By Component
- 6.4.1. Traction Battery Pack
- 6.4.2. Powertrain
- 6.4.3. Others (Thermal System, Body & Chassis, Braking, Wheels & Suspension System etc.)
- 6.5. Market Analysis – By Country
- 6.5.1. The U.S.
- 6.5.1.1. By Propulsion Type
- 6.5.1.2. By Battery Capacity
- 6.5.2. Canada
- 6.5.2.1. By Propulsion Type
- 6.5.2.2. By Battery Capacity
- 6.5.3. Mexico
- 6.5.3.1. By Propulsion Type
- 6.5.3.2. By Battery Capacity
- 7. Europe Electric Van Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast – By Propulsion Type
- 7.1.1. Battery Electric Vehicle (BEV)
- 7.1.2. Hybrid Vehicle (HEV)
- 7.2. Market Analysis, Insights and Forecast – By Range
- 7.2.1. Up to 100 Miles
- 7.2.2. 100-200 Miles
- 7.2.3. Above 200 Miles
- 7.3. Market Analysis, Insights and Forecast – By Battery Capacity
- 7.3.1. Up to 50 kWh
- 7.3.2. Above 50 kWh
- 7.4. Market Analysis, Insights and Forecast – By Component
- 7.4.1. Traction Battery Pack
- 7.4.2. Powertrain
- 7.4.3. Others (Thermal System, Body & Chassis, Braking, Wheels & Suspension System etc.)
- 7.5. Market Analysis – By Country
- 7.5.1. The U.K
- 7.5.1.1. By Propulsion Type
- 7.5.1.2. By Battery Capacity
- 7.5.2. Germany
- 7.5.2.1. By Propulsion Type
- 7.5.2.2. By Battery Capacity
- 7.5.3. France
- 7.5.3.1. By Propulsion Type
- 7.5.3.2. By Battery Capacity
- 7.5.4. Rest of Europe
- 7.5.4.1. By Propulsion Type
- 7.5.4.2. By Battery Capacity
- 8. Asia Pacific Electric Van Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast – By Propulsion Type
- 8.1.1. Battery Electric Vehicle (BEV)
- 8.1.2. Hybrid Vehicle (HEV)
- 8.2. Market Analysis, Insights and Forecast – By Range
- 8.2.1. Up to 100 Miles
- 8.2.2. 100-200 Miles
- 8.2.3. Above 200 Miles
- 8.3. Market Analysis, Insights and Forecast – By Battery Capacity
- 8.3.1. Up to 50 kWh
- 8.3.2. Above 50 kWh
- 8.4. Market Analysis, Insights and Forecast – By Component
- 8.4.1. Traction Battery Pack
- 8.4.2. Powertrain
- 8.4.3. Others (Thermal System, Body & Chassis, Braking, Wheels & Suspension System etc.)
- 8.5. Market Analysis – By Country
- 8.5.1. China
- 8.5.1.1. By Propulsion Type
- 8.5.1.2. By Battery Capacity
- 8.5.2. India
- 8.5.2.1. By Propulsion Type
- 8.5.2.2. By Battery Capacity
- 8.5.3. Japan
- 8.5.3.1. By Propulsion Type
- 8.5.3.2. By Battery Capacity
- 8.5.4. Rest of Asia Pacific
- 8.5.4.1. By Propulsion Type
- 8.5.4.2. By Battery Capacity
- 9. Rest of the World Electric Van Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast – By Propulsion Type
- 9.1.1. Battery Electric Vehicle (BEV)
- 9.1.2. Hybrid Vehicle (HEV)
- 9.2. Market Analysis, Insights and Forecast – By Range
- 9.2.1. Up to 100 Miles
- 9.2.2. 100-200 Miles
- 9.2.3. Above 200 Miles
- 9.3. Market Analysis, Insights and Forecast – By Battery Capacity
- 9.3.1. Up to 50 kWh
- 9.3.2. Above 50 kWh
- 9.4. Market Analysis, Insights and Forecast – By Component
- 9.4.1. Traction Battery Pack
- 9.4.2. Powertrain
- 9.4.3. Others (Thermal System, Body & Chassis, Braking, Wheels & Suspension System etc.)
- 10. Competitive Analysis
- 10.1. Key Industry Development
- 10.2. Global Market Ranking Analysis (2023)
- 10.3. Competition Dashboard
- 10.4. Comparative Analysis – Major Players
- 10.5. Company Profiles
- 10.5.1. Mercedes-Benz Group AG (Germany)
- 10.5.1.1. Overview
- 10.5.1.2. Products & Services
- 10.5.1.3. SWOT Analysis
- 10.5.1.4. Recent Developments
- 10.5.1.5. Strategies
- 10.5.1.6. Financials (Based on Availability)
- 10.5.2. BYD Company Ltd (China)
- 10.5.2.1. Overview
- 10.5.2.2. Products & Services
- 10.5.2.3. SWOT Analysis
- 10.5.2.4. Recent Developments
- 10.5.2.5. Strategies
- 10.5.2.6. Financials (Based on Availability)
- 10.5.3. General Motors (U.S.)
- 10.5.3.1. Overview
- 10.5.3.2. Products & Services
- 10.5.3.3. SWOT Analysis
- 10.5.3.4. Recent Developments
- 10.5.3.5. Strategies
- 10.5.3.6. Financials (Based on Availability)
- 10.5.4. Renault (France)
- 10.5.4.1. Overview
- 10.5.4.2. Products & Services
- 10.5.4.3. SWOT Analysis
- 10.5.4.4. Recent Developments
- 10.5.4.5. Strategies
- 10.5.4.6. Financials (Based on Availability)
- 10.5.5. Volkswagen Group (Germany)
- 10.5.5.1. Overview
- 10.5.5.2. Products & Services
- 10.5.5.3. SWOT Analysis
- 10.5.5.4. Recent Developments
- 10.5.5.5. Strategies
- 10.5.5.6. Financials (Based on Availability)
- 10.5.6. Toyota Motor Corporation (Japan)
- 10.5.6.1. Overview
- 10.5.6.2. Products & Services
- 10.5.6.3. SWOT Analysis
- 10.5.6.4. Recent Developments
- 10.5.6.5. Strategies
- 10.5.6.6. Financials (Based on Availability)
- 10.5.7. Hyundai Motor Company (South Korea)
- 10.5.7.1. Overview
- 10.5.7.2. Products & Services
- 10.5.7.3. SWOT Analysis
- 10.5.7.4. Recent Developments
- 10.5.7.5. Strategies
- 10.5.7.6. Financials (Based on Availability)
- 10.5.8. Honda Motor Company Ltd. (Japan)
- 10.5.8.1. Overview
- 10.5.8.2. Products & Services
- 10.5.8.3. SWOT Analysis
- 10.5.8.4. Recent Developments
- 10.5.8.5. Strategies
- 10.5.8.6. Financials (Based on Availability)
- 10.5.9. Nissan Motor Co. ltd (Japan)
- 10.5.9.1. Overview
- 10.5.9.2. Products & Services
- 10.5.9.3. SWOT Analysis
- 10.5.9.4. Recent Developments
- 10.5.9.5. Strategies
- 10.5.9.6. Financials (Based on Availability)
- 10.5.10. Stellantis N.V. (Netherlands)
- 10.5.10.1. Overview
- 10.5.10.2. Products & Services
- 10.5.10.3. SWOT Analysis
- 10.5.10.4. Recent Developments
- 10.5.10.5. Strategies
- 10.5.10.6. Financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook